These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 463409)
21. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer]. Ohta M; Tomoda Y; Kano T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004 [TBL] [Abstract][Full Text] [Related]
22. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812 [TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma. Erickson LD; Hartmann LC; Su JQ; Nielsen SN; Pfeifel DM; Goldberg RM; Levitt R; Stanhope CR Gynecol Oncol; 1994 Aug; 54(2):196-200. PubMed ID: 8063245 [TBL] [Abstract][Full Text] [Related]
24. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy in the management of ovarian germ cell malignancies. Schwartz PE Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473 [TBL] [Abstract][Full Text] [Related]
26. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
27. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark. Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480 [TBL] [Abstract][Full Text] [Related]
28. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Aletti GD; Long HJ; Podratz KC; Cliby WA Gynecol Oncol; 2007 Jan; 104(1):212-6. PubMed ID: 17023033 [TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma. Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714 [TBL] [Abstract][Full Text] [Related]
33. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Ayhan A; Gultekin M; Taskiran C; Aksan G; Celik NY; Dursun P; Salman MC; Yuce K; Kucukali T Am J Obstet Gynecol; 2006 Jan; 194(1):49-56. PubMed ID: 16389009 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of platinum plus cyclophosphamide in patients with epithelial ovarian cancer. Tangjitgamol S; Mamusirinitaya S; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P; Sittidilokratna K J Med Assoc Thai; 2005 Sep; 88(9):1172-81. PubMed ID: 16536101 [TBL] [Abstract][Full Text] [Related]
35. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma]. Zhao XD; Zhang Q; Zhang Y Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882 [TBL] [Abstract][Full Text] [Related]
36. Ovarian cancer: an analysis of forty-four patients at the National Radiotherapy Centre, Accra--Ghana. Vanderpuye V; Yarney J West Afr J Med; 2007; 26(2):93-6. PubMed ID: 17939307 [TBL] [Abstract][Full Text] [Related]
37. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)]. Teufel G; Pfleiderer A Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795 [TBL] [Abstract][Full Text] [Related]
38. [Results of fertility preserving operations in malignant ovarian tumors]. Kleine W Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006 [TBL] [Abstract][Full Text] [Related]
39. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972 [TBL] [Abstract][Full Text] [Related]